Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies in the world whose chemoprevention became increasingly important in HCC treatment. Although the anticancer effects of asparagus constituents have been investigated in several cancers, its effects on hepatocellular carcinoma have not been fully studied. In this study, we investigated the anticancer effects of the deproteinized asparagus polysaccharide on the hepatocellular carcinoma cells using the in vitro and in vivo experimental model. Our data showed that deproteinized asparagus polysaccharide might act as an effective inhibitor on cell growth in vitro and in vivo and exert potent selective cytotoxicity against human hepatocellular carcinoma Hep3B and HepG2 cells. Further study showed that it could potently induce cell apoptosis and G2/M cell cycle arrest in the more sensitive Hep3B and HepG2 cell lines. Moreover, deproteinized asparagus polysaccharide potentiated the effects of mitomycin both in vitro and in vivo. Mechanistic studies revealed that deproteinized asparagus polysaccharide might exert its activity through an apoptosis-associated pathway by modulating the expression of Bax, Bcl-2, and caspase-3. In conclusion, deproteinized asparagus polysaccharide exhibited significant anticancer activity against hepatocellular carcinoma cells and could sensitize the tumoricidal effects of mitomycin, indicating that it is a potential therapeutic agent (or chemosensitizer) for liver cancer therapy.
This is a preview of subscription content, log in to check access.
This work was supported by the grant from National Natural Science Foundation of China (30973823), the grant of Shanghai City Population and Family Planning Commission of Science and Technology Development Fund Project (2010JG04), the special grant from the China Postdoctoral Science Foundation (2013 T60791), and the Key Laboratory Construction grant (SW201110010) from Science, Industry, Trade, and Information Technology Commission of Shenzhen Municipality.
Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004;126:1005–14.PubMedCrossRefGoogle Scholar
Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008;48 Suppl 1:S20–37.PubMedCrossRefGoogle Scholar
Tanaka T, Kohno H, Mori H. Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds. Asian Pac J Cancer Prev. 2001;2:165–77.PubMedGoogle Scholar
Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, et al. New agents for cancer chemoprevention. J Cell Biochem Suppl. 1996;26:1–28.PubMedGoogle Scholar
Corpet DE, Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer. 2002;43:1–21.PubMedCentralPubMedCrossRefGoogle Scholar
Shao Y, Chin CK, Ho CT, Ma W, Garrison SA, Huang MT. Anti-tumor activity of the crude saponins obtained from asparagus. Cancer Lett. 1996;104:31–6.PubMedCrossRefGoogle Scholar
Shao Y, Poobrasert O, Kennelly EJ, Chin CK, Ho CT, Huang MT, et al. Steroidal saponins from Asparagus officinalis and their cytotoxic activity. Planta Med. 1997;63:258–62.PubMedCrossRefGoogle Scholar
Makris DP, Rossiter JT. Domestic processing of onion bulbs (Allium cepa) and asparagus spears (Asparagus officinalis): effect on flavonol content and antioxidant status. J Agric Food Chem. 2001;49:3216–22.PubMedCrossRefGoogle Scholar
Wang M, Tadmor Y, Wu QL, Chin CK, Garrison SA, Simon JE. Quantification of protodioscin and rutin in asparagus shoots by LC/MS and HPLC methods. J Agric Food Chem. 2003;51:6132–6.PubMedCrossRefGoogle Scholar
Villanueva-Suarez MJ, Redondo-Cuenca A, Rodriguez-Sevilla MD, Heredia-Moreno A. Postharvest storage of white asparagus (Asparagus officinalis L.): changes in dietary fiber (nonstarch polysaccharides). J Agric Food Chem. 1999;47:3832–6.PubMedCrossRefGoogle Scholar
Yamamori A, Onodera S, Kikuchi M, Shiomi N. Two novel oligosaccharides formed by 1f-fructosyltransferase purified from roots of asparagus (Asparagus officinalis L.). Biosci Biotechnol Biochem. 2002;66:1419–22.PubMedCrossRefGoogle Scholar
Rodriguez R, Jaramillo S, Rodriguez G, Espejo JA, Guillen R, Fernandez-Bolanos J, et al. Antioxidant activity of ethanolic extracts from several asparagus cultivars. J Agric Food Chem. 2005;53:5212–7.PubMedCrossRefGoogle Scholar
Jang DS, Cuendet M, Fong HH, Pezzuto JM, Kinghorn AD. Constituents of Asparagus officinalis evaluated for inhibitory activity against cyclooxygenase-2. J Agric Food Chem. 2004;52:2218–22.PubMedCrossRefGoogle Scholar
Zhu X, Zhang W, Zhao J, Wang J, Qu W. Hypolipidaemic and hepatoprotective effects of ethanolic and aqueous extracts from Asparagus officinalis L. by-products in mice fed a high-fat diet. J Sci Food Agric. 2010;90:1129–35.PubMedCrossRefGoogle Scholar
Wang H, Ng TB. Isolation of a novel deoxyribonuclease with antifungal activity from Asparagus officinalis seeds. Biochem Biophys Res Commun. 2001;289:120–4.PubMedCrossRefGoogle Scholar
Liu W, Huang XF, Qi Q, Dai QS, Yang L, Nie FF, et al. Asparanin A induces G(2)/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Biochem Biophys Res Commun. 2009;381:700–5.PubMedCrossRefGoogle Scholar
Bousserouel S, Le Grandois J, Gosse F, Werner D, Barth SW, Marchioni E, et al. Methanolic extract of white asparagus shoots activates trail apoptotic death pathway in human cancer cells and inhibits colon carcinogenesis in a preclinical model. Int J Oncol. 2013;43:394–404.PubMedCentralPubMedGoogle Scholar
Wang J, Liu Y, Zhao J, Zhang W, Pang X. Saponins extracted from by-product of Asparagus officinalis L. suppress tumour cell migration and invasion through targeting Rho GTPase signalling pathway. J Sci Food Agric. 2013;93(6):1492–8.PubMedCrossRefGoogle Scholar
Wang J, Liu Y, Zhao J, Zhang W, Pang X. Saponins extracted from by-product of Asparagus officinalis L. suppress tumour cell migration and invasion through targeting Rho GTPase signalling pathway. J Sci Food Agric. 2013;93:1492–8.PubMedCrossRefGoogle Scholar
Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 1995;181:1661–72.PubMedCrossRefGoogle Scholar